7 results
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
due to #COVID19 ... #management ... #covid19 #treatment ... #sarscov2 #criticalcare ... #coronavirus #medications
Recent studies have revealed many attractive therapeutic options, even if some of them remain to be
clinical trials #covid19 ... #sarscov2 #management ... #treatment #coronavirus ... #medications
Extrapulmonary manifestations of COVID-19
 • Neurologic: Headaches, Dizziness, Encephalopathy, Guillain-Barré, Ageusia, Myalgia, Anosmia, Stroke
 • Renal:
manifestations of COVID ... -19 • Neurologic ... Encephalopathy, Guillain-Barré ... Signs #Symptoms #SARSCOV2 ... #coronavirus
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Syndrome ... Pathophysiology ... like illnesses, COVID ... #management #treatment ... #neurology
COVID-19 Intubation Checklist

Personal protective equipment (PPE)
 • Standard PPE
   • N95 or PAPR.
COVID-19 Intubation ... Medications & pre-planned ... Intubation #Checklist #SARSCoV2 ... #Management #CriticalCare ... #Coronavirus
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... the underlying pathophysiology ... GBS #Guillain #Barre ... #Syndrome #diagnosis ... #management #neurology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
may precede the neurologic ... Etiology: • Pathophysiology ... Electrolyte abnormality, Medication ... #diagnosis #management ... #neurology